Navigation Links
AEterna Zentaris Announces Completion of Phase 1 Study with Oral AEZS-112 in Cancer
Date:9/21/2009

cokinetic study on weekly oral AEZS-112, a small molecule anti-cancer agent in patients with advanced cancer and lymphoma", was presented by D. W. Northfelt, M.D.

About AEterna Zentaris Inc.

AEterna Zentaris Inc. is a global biopharmaceutical company focused on endocrine therapy and oncology, with proven expertise in drug discovery, development and commercialization. News releases and additional information are available at www.aezsinc.com.

Forward-Looking Statements

This press release contains forward-looking statements made pursuant to the safe harbor provisions of the U.S. Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties, which could cause the Company's actual results to differ materially from those in the forward-looking statements. Such risks and uncertainties include, among others, the availability of funds and resources to pursue R D projects, the successful and timely completion of clinical studies, the ability of the Company to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. Investors should consult the Company's quarterly and annual filings with the Canadian and U.S. securities commissions for additional information on risks and uncertainties relating to the forward-looking statements. Investors are cautioned not to rely on these forward-looking statements. The Company does not undertake to update these forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future results, events or developments except if we are required by a governmental authority or applicable law.


'/>"/>
SOURCE AETERNA ZENTARIS INC.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. AEterna Zentaris Partner, Keryx Biopharmaceuticals, Receives Orphan-Drug Designation for Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
2. AEterna Zentaris to Present at Upcoming Rodman Renshaw Annual Global Investment Conference
3. AEterna Zentaris Announces Results from Two Phase 3 Studies with Cetrorelix in Benign Prostatic Hyperplasia
4. AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results
5. AEterna Zentaris to Present at Upcoming Canaccord Adams 29th Annual Global Growth Conference
6. AEterna Zentaris to Announce Second Quarter 2009 Financial and Operating Results on August 11, 2009
7. AEterna Zentaris Partner, Keryx, Announces Agreement with FDA on a Special Protocol Assessment for Phase 3 Trial with Perifosine (KRX-0401) for the Treatment of Multiple Myeloma
8. AEterna Zentaris: New Data Published on its Ghrelin Antagonist Compound, AEZS-123 (JMV2959), Supports its Use in Alcohol Addiction
9. AEterna Zentaris Receives US$10 Million from Institutional Investors
10. AEterna Zentaris to Report Data from Safety Study of Phase 3 Program in Benign Prostatic Hyperplasia with Cetrorelix Ahead of Schedule
11. AEterna Zentaris Opens Extended Study for Cetrorelix in Benign Prostatic Hyperplasia

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... surgeons and recognized refractive and cataract s...de brought their fellow surgeons up-to-date on the... cataract surgery, and ophthalmology in general at...lmology (AAO) annual meeting in San Francisco, Cal..., Dr. David Huang, MD, Dr. Randy Epstein, Dr. Will...
(Date:11/19/2009)... November 19 AFFiRiS AG will focus...ndidate at an unexpectedly early,stage of developm...r into,Phase II clinical trial early in 2010. This...ompletion of two Phase I trials with the candidate...on on the first interim,analysis of the secondary ...
(Date:11/18/2009)... able to find explosive materials and persons who ...es, the National Institute of Standards and Techno...omeland Security, has developed a new certified re...) 2905, Trace Particulate Explosives. Compatible w...ll be helpful in calibrating, testing and developi...
(Date:11/18/2009)...18 Sangamo BioSciences, ...om the University of Pennsylvania investigator spo...er nuclease (ZFN) based product, SB-728-T, for HIV... on the internet. ,, Data were presented in a s...hool of Medicine from a single subject treated wit...
Breaking Biology Technology:Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 2Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 3Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 4Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 5Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 6Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 7Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 8Experts Listed at Trusted LASIK Surgeons Bring Peers Up to Date on Vision Correction and Cataract Surgery at Annual AAO Meeting 9AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3New NIST trace explosives standard slated for homeland security duty 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2
... 8 Applied Isotope Technologies ("AIT"),announced...very Products,will be exclusively used for the ana...lic biochemical assessment when they are placed in... at The Children,s Institute,in Pittsburgh, PA. Sc...orders (ASD) will lead a team of scientists for th...
...if., May 8 Neurobiological,Technologies, Inc. (NT...lease,its third quarter 2008 financial results, fo... and host a conference call on May 13, 2008., Hos...nd Chief Executive,Officer, and Matthew M. Loar, V...ails for the call are as follows:, -- Date: Tue...
...., May 8 BioCryst,Pharmaceuticals, Inc. (Nasdaq: ...quarter ended March 31, 2008. The Company reported...compared to $9.2M in the first quarter of,2007. Th...s $13.1M, or,$0.34 per share, compared to a net lo...r $0.30 per share., Research and development (R&D...
Other Biology Technology:Applied Isotope Technologies will Exclusively Supply Biochemimarker(TM) Discovery Products for a Unique Pilot Study on Autism 2Neurobiological Technologies Sets Date for Third Quarter Financial Results 2BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 2BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 3BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 4BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 5BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 6BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 7BioCryst Reports First Quarter 2008 Financial Results and Clinical Update 8
(Date:11/19/2009)...ADISON Leaf-cutter ants, which cultivate fungus f...,s a new one to add to the list: the ant farmers, ...fixing bacteria to make their gardens grow. The fi... Science , documents a previously unknown symbios...into how leaf-cutter ants have come to dominate th...
(Date:11/19/2009)...n a massive survey of genetic diversity in maize, ...States, have developed a gene map that should pave...at is a major source of food, fuel, animal feed an...al type of gene map known as a haplotype map, char...genome of 27 inbred lines of maize. The research t...
(Date:11/19/2009)...EST LAFAYETTE, Ind. - Purdue University scientists...to be responsible for cell wall development in mai...er ways to produce the biomass best suited for bio...y Nicholas Carpita, a professor of plant cell biol... genes in the journal Plant Physiology on Thursd...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2Maize cell wall genes identified, giving boost to biofuel research 2Dental Educator to Receive the ADA Distinguished Service Award 58782 1Dental Educator to Receive the ADA Distinguished Service Award 58782 2Dental Educator to Receive the ADA Distinguished Service Award 58782 3Vermillion Announces Return of Eric Fung M D Ph D 14338 1Vermillion Announces Return of Eric Fung M D Ph D 14338 2Vermillion Announces Return of Eric Fung M D Ph D 14338 3Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2009 Results 5194 1
...for European collaboration on climate research goe...nt of Physical Geography and Quaternary Geology. ,...ean Project for Ice Coring in Antarctica), is one ...ollaborative Transnational Research. The prize of ...h March 2008, is shared by three highly prominent ...
...uence that a stress-related hormone has on learnin...rstanding how it influences human learning, accord... Mateo, Assistant Professor in Comparative Human D...l survival tasks, ground squirrels learn more quic...rmone produced in response to stress, than those w...
...inciple of "strength in numbers" more apparent tha...ir simplicity, these one-cell organisms -- which n..., that is not a typo) on Earth -- affect virtually...ic material to the production of oxygen. , But ev...entists have never before been able to conduct com...
Other Biology News:Research with squirrels provides clues on hormone's role in human learning 2New window opens on the secret life of microbes 2
Mouse Anti-Guinea Pig T-Cells, Pan Monoclonal Antibody, FITC Conjugated from AbD Serotec
Canine Serum from CHEMICON
...d (40kb), and large plasmid insert (10-20kb) DNAs..... On command 20-50 fold copy amplification for hig...ailable with blue-white screening (pEZ BAC) or tra...t insert stability. Kits include electrocompetent ...
Rabbit Anti-GLYCINE Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: